Compare Multitrend Indo Tbk (BABY) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multitrend Indo Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multitrend Indo Tbk trades at Rp174 (market cap 485.32B, 589.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Multitrend Indo Tbk is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Multitrend Indo Tbk is more actively traded (589.3K versus 214.9K). Which is the better fit depends on your goals.
| BABY | OBAT | |
|---|---|---|
Market Cap | 485.32B | 164.65B |
Volume | 589.3K | 214.9K |
Lot | 5.89K | 2.15K |
Turnover | 101.82M | 51.97M |
Average Price | 172.78 | 241.85 |
Value | 101.82M | 51.97M |
Indicative Equilibrium Price | 174 | 240 |
Indicative Equilibrium Volume | 60 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multitrend Indo Tbk
PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.
Read more on BABY →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
